DVA

NYSE DaVita Inc.

Oct 10, 2026 · 5:31 PM ET EOD Market Closed

$179.25 ↑ +0.00 (+0.00%) Trading Up from the previous close of $179.25, $0.86 below the day’s high of $180.11

YTD change: +57.78%
vs 20-day SMA: -1.00%
vs 200-day SMA: +4.64%

Price ranges

Previous day

$177.00 $180.11

open $177.00 close $179.25

+$2.25 (+1.27%)

Today

$177.00 $180.11

$179.25

Past week

$175.41 $182.61

from $176.35 now $179.25

+$2.90 (+1.64%)

Past month

$173.95 $195.75

from $181.33 now $179.25

-$2.08 (-1.15%)

This year

$101.00 $247.49

from $113.61 now $179.25

+$65.64 (+57.78%)

Price & Performance

+29.20 (+19.46%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Neutral

The stock is 27.6% away from all-time highs of $247.49
DVA is up 58% since the beginning of the year
DVA is up 42% over the past 12 months
DVA is down 1% over the past 1 month
7% of all DVA investors are betting against DVA
Number of investors short DVA has gone down 8% versus last month

DVA reads neutral: price sits above one of the two key moving averages, short interest is falling month over month, the 12-month move is +44.6%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable Yes

EPS $4.02

Earnings momentum -12.5% Quarterly EPS growth

Quarterly change -12.5%

Valuation

P/E ratio 14.55

Enterprise value $26.2B

Beta 1.17

Balance sheet & scale

Income$822.5K

Revenue$14.0B

Cash$771.8M

Debt$13.4M

Income / Debt 0.06×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNYSE

Sector Health Care and Social Assistance

Sub Sector Ambulatory Health Care Services

Market cap $11.4B

DaVita, Inc. engages in the provision of medical care services. It operates through the US Dialysis and Related Lab Services, and Other-Ancillary Services and Strategic Initiatives segments. The US Dialysis and Related Lab Services segment offer kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consists primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.

Competitor comparison

Ticker	Company	Price	Change
CI	Cigna Group	$282.43	+0.50%
CNC	Centene Corporation	$65.36	+1.27%
FMS	Fresenius Medical Care AG Sponsored ADR	$21.06	+0.86%
MOH	Molina Healthcare, Inc.	$196.93	+0.60%
USPH	U.S. Physical Therapy, Inc.	$84.67	+1.38%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.